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Abstract  Oxidative stress designates the state of 
imbalance between reactive oxygen species (ROS) 
production and antioxidant levels. In a healthy placenta, 
there is an increase in ROS production, due to formation 
of new tissues and inherent metabolism, but this is 
balanced by higher levels of antioxidants. However, 
this balance is lost in some situations, with a 
consequent increase in oxidative stress levels. 
Oxidative stress has been implicated in several 
placental disorders and pregnancy pathologies. The 
present review intends to summarize what is known 
about the relationship between oxidative stress and 
well-known pregnancy disorders. 
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Oxidative stress 
 
Oxidative stress is the term used to designate an 
imbalance between reactive oxygen species (ROS) and 
anti- oxidant levels in a cell, favoring the former 
(Burton and Jauniaux 2011; Dalle-Donne et al. 2006; 
Dröge 2002; Halliwell 2003). ROS include free-radical 
intermediates such as superoxide anion radical (O2·
−
; 
the most abundant under physiological conditions 
(Burton and Jauniaux 2011)), hydroxyl radical (HO·), 
peroxyl radical (ROO·), alkoxyl radical (RO·), and 
hydroperoxyl radical (HO·2),  and non-radical 
intermediates such as hydrogen peroxide (H2O2), 
ozone (O3), hypochlorous acid (HOCl), peroxynitrite 
(ONOO–), and singlet oxy- gen (1O2). These 
compounds have high instability due to the existence 
of one or more, unpaired electrons (Aherne and 
O’Brien  2000; Dalle-Donne et al. 2003; Valko et al. 
2007). ROS can be generated from multiple 
mechanisms. Some of its sources include the following: 
& Normal metabolic reactions such as redox 
reactions during cell respiration. O2 reduction to water 
implies a 1–2 % electron leakage, generating O2·
−  
at 
the ubiquinone and NADH dehydrogenase (complex I) 
level, as well as in complex III; 
&       Radiation, exciting UV rays, and ionizing X rays; 
&       Xenobiotics and drug metabolism; 
& The activity of monoamine oxidase, which 
deaminates biogenic amines. This mechanism 
occurs at the outer membrane of the 
mitochondria and is associated to large H2O2  
production; 
&       In purine catabolism and formation of uric acid, 
in the reactions catalyzed by xanthine oxidase, a 
O2·
−-producing enzyme (Myatt and Cui 2004); 
& In the reactions catalyzed by xanthine 
oxidoreductase, nicotinamide adenine dinucleotide 
phosphate (NAD(P)H) oxidase, nitric oxide 
synthase, and heme  oxygenase,  and  in  the  
formation  o f peroxynitrite (Myatt and Cui 2004); 
& during an inflammatory response, the production of 
H2O2   and O2·
− greatly
 increases in cells such as 
polymorphonuclear cells, eosinophils, monocytes, 
Kupffer cells, and macrophages, thanks to a highly 
specialized NAD(P)H-dependent oxidase system 
located in the outer surface of the cell 
membrane, coupled to the action of superoxide 
dismutase (SOD) (Burton and Jauniaux 2011; Poli 
et al. 2004); 
& during protein folding taking place in the 
endoplasmic reticulum, where a significant amount 
of O2·
− 
is formed. In this process, the formation of 
disulfide bonds is an oxidative process, since it 
involves the oxidation of sulfhydryl groups of 
cysteine residues (Burton and Jauniaux 2011; 
Burton et al. 2009; Poli et al. 2004). 
 
  
 
ROS measurement is difficult because of high 
reactivity, very short half-life, and low 
concentrations. Therefore, indirect markers such as 
malondialdehyde are commonly used to evaluate 
secondary products of ROS damage. 
At homeostatic levels, ROS are implicated in diverse 
actions on cell function, including activation of redox- 
sensitive transcription factors and activation of protein 
kinases (Burton and Jauniaux 2011), regulation of 
vascular tone and functions controlled by O2 
c o n c e n t r a t i o n s , enhancement of signal transduction 
from many membrane receptors (e.g., the antigen 
receptor of lymphocytes) (Dröge 2002), combating 
pathogens (Myatt and Cui 2004), among others. 
However, when in excess, ROS can induce cell 
injury and a chronic inflammatory state that can 
trigger a cascade of free-radical reactions, 
promoting secondary ROS generation and 
resulting in cellular modification and damage in 
DNA, carbohydrates, proteins, and polyunsaturated 
fatty acids. This oxidative injury follows a general 
pattern that involves free thiol oxidation and 
formation of disulfide proteins, depletion of the ATP 
pool, free cytosolic Ca
2+  
increment, disintegration of 
cytoskeleton, increase in membrane lipid 
peroxidation, release of cytosolic compounds, and 
DNA damage (Aherne and O'Brien 2000; Dalle- 
Donne et al. 2006; Poston et al. 2011). Examples of 
human conditions associated with increased 
oxidative state include cellular aging, brain 
dysfunction and neurodegenerative diseases, 
cancer, diabetes, rheumatoid arthritis, and  
cardiovascular and renal diseases (Dröge 2002; 
Mitjavila and Moreno 2012; Silva and Soares-da-
Silva 2007; Valko et al. 2007). 
 
 
Oxidative stress and the placenta 
 
In a healthy placenta, there is an increase in 
oxidative stress levels, due to a high placental 
mitochondrial activity resulting in an increase in ROS 
production (Myatt and Cui 2004). However, this is 
accompanied by an increase in antioxidant protection 
(such as the activity of the enzymes superoxide 
dismutase, catalase, and glutathione peroxidase), 
which compensates for the in- crease in ROS 
production 
 
 (Coughlan et al. 2004b). In this way, the balance 
between ROS and antioxidants stays preserved. 
During normal placental development, ROS seem to 
have important roles. In the first trimester, placental O2 
levels are relatively low, with a pressure around 
20 mmHg (Tuuli et al. 2011), due to lack of established 
maternal intraplacental circulation, which is believed to 
be the reason why the embryo is particularly protected 
from ROS at that time. These low O2 levels are essential 
for normal cell proliferation and placental angiogenesis, 
promoted by hypoxia-induced transcriptional and post- 
transcriptional regulation of angiogenic factors such as 
vascular endothelial growth factor and placental growth 
factor (Tuuli et al. 2011). However, once maternal 
intraplacental circulation is fully established (toward 
the end of the first trimester), the O2  tension triples 
and, with it, so does ROS levels, particularly at the 
syncytiotrophoblastic layer (Burton and Jauniaux 
2011; Burton et al. 2010). The placenta then adapts to 
this increase by modulating hypoxia-inducible factor 1α 
(HIF-1α) and increasing cellular antioxidant levels 
(Tuuli et al. 2011). Under normal conditions, this 
adaptation is favorable to fetal development. For 
example, some studies suggest that NAD(P)H oxidase 
can act as an “oxygen  sensor,”  regulating 
differentiation of cytotrophoblasts into 
syncytiotrophoblasts when O2 tension increases, and 
vascular endothelial growth factor A (VEGF-A) and 
metalloproteins are sensitive to oxidative stress 
(Poston and Raijmakers 2004). Also, super- oxide 
activates cytokine synthesis and, therefore, much 
probably plays a role in the maternal inflammatory state 
that characterizes a normal pregnancy (Poston and 
Raijmakers 2004). 
As mentioned above, increased oxidative stress is 
inherent to increased ROS levels observed in a normal 
pregnancy. However, in a scenario where oxidative 
stress is abnormally increased, damage affecting both 
the mother and the fetus can be observed. Several 
studies have been conducted for the last two decades 
that relate increased oxidative stress levels to several 
pregnancy pathologies, including gestational 
diabetes mellitus, spontaneous abortion, idiopathic 
recurrent pregnancy loss, defective 
embryogenesis, drug- induced teratogenicity, 
preeclampsia, intrauterine growth restriction, and 
minor congenital abnormalities, as well as to future 
diseases in adulthood such as obesity, diabetes mellitus, 
and hypertension 
  
 
 (Burton et al. 2009, 2010; Dröge 2002; Hempstock et 
al. 2003; Myatt 2010; Poston et al. 2011; Shibata et al. 
2010; Theuerkauf et al. 2010; Tuuli et al. 2011). 
Over the next sections, the relationship between 
oxidative stress and well-known pregnancy 
pathologies will be presented. 
 
 
 
Oxidative stress and pregnancy  disorders 
 
Gestational diabetes mellitus (GDM) 
 
GDM is a type of diabetes mellitus where a healthy 
pregnant woman develops glucose intolerance of 
varying severity (Coughlan et al. 2004b). Although it 
was classically estimated to develop in 2–5 % of 
pregnancies, according to the new International 
Association of the Diabetes and Pregnancy Study 
Groups (IADPSG) Consensus Panel diagnostic criteria, 
the prevalence has significantly increased to about 18 % 
of all pregnancies (Sacks et al. 2012). GDM develops 
around the second half of gestation (by the time the 
placental villi undergoes extensive angiogenesis and 
vascularization) and has a significant role in fetal 
macrosomia, perinatal mortality, and long-term risk of 
developing type 2 diabetes mellitus for the mother, 
which is why it is considered a “pre-diabetic” state 
(Coughlan et al. 2004b; Gauster et al. 2012; Myatt and 
Cui 2004). 
In diabetes mellitus, ROS are thought to be produced 
in excess as a result of prolonged periods of exposure to 
hyperglycemia, which is known to cause nonenzymatic 
glycation of plasma proteins (Myatt and Cui 2004). 
Glucose undergoes auto-oxidation, forming free- 
radical hydroxilic anions which overwhelm the 
antioxidant cellular responses. So, the high blood 
glucose levels affect the surrounding vasculature, 
causing the endothelium to be more sensitive to 
free radicals (Leach et al. 2009). Several studies 
have identified increased levels of biomarkers of 
ROS damage and abnormalities in the antioxidant 
defenses in diabetic patients (Coughlan et al. 
2004b). For instance, carbonylated proteins, one of 
the most used markers of protein oxidation as a result 
of oxidative stress, are found in significantly higher 
levels in erythrocyte membranes in individuals with 
type 2 diabetes mellitus and correlates with impaired 
glycemic control (Coughlan et al. 2004b). 
 
In relation to GDM, both the placental protein 
carbonyl content and the release of 8-isoprostane (8-
IP), a stable and sensitive indicator of in vivo lipid 
peroxidation, were found to be greater when compared to 
healthy pregnant women (Coughlan et al. 2004b). 
This was associated with an increased activity and 
gene expression of antioxidant enzymes such as 
catalase, glutathione reductase, and CuZn-SOD (Al-
Shebly and Mansour 2012; Coughlan et al. 2004b; 
Lappas et al. 2010). Additionally, adaptation to 
exogenous oxidative stress was tested in placental 
tissues from women with and without GDM, in order 
to investigate if women with GDM would be less 
responsive to oxidative stress. Interestingly enough, 
based on the analysis of 8-IP and tumor necrosis factor 
alpha (TNFα) release and nuclear factor-kappaB (NF-
κB) activity and on the analysis of cytokine release 
and antioxidant enzyme activity (catalase and 
glutathione reductase), respectively, both studies 
concluded that GDM placenta have a reduced capacity 
to respond to exogenous oxidative stress (Coughlan et 
al. 2004b; Lappas et al. 2010), mediated by a repression 
of NF-κB (Coughlan et al. 2004a). In contrast, a very 
recent study did not find differences in both oxidative 
stress biomarkers (malondialdehyde (MDA) and 
protein carbonyls) and antioxidant capacity (GSSG, 
reduced glutathione (GSH) and glutathione peroxidase) 
between control and GDM placentas (Araújo et al. 
2013). However, as stressed by the authors, the reason 
for the apparent discrepancy relates to the fact that 
women in the GDM group were diagnosed according 
to the new IADPSG criteria (Sacks et al. 2012), which 
encompass women with a less severe diabetic 
phenotype. For most of the abovementioned studies, 
GDM women were treated by controlled nutrition and/or 
insulin administration. 
The use of antioxidant therapy in GDM has been 
investigated in the past. Antioxidant administration 
was found to decrease oxidative stress levels and in- 
crease antioxidant capacity (Asemi et al. 2013; 
Cederberg et al. 2001; Ley et al. 2013; Liang et al. 2009; 
Lorenzoni et al. 2013; Makni et al. 2011; Sakamaki et al. 
1999; Wentzel and Eriksson 2005; Yessoufou et al. 
2006) and to decrease fasting blood glucose, 
insulin resistance, and inflammation (Asemi et al. 
2013; Ley et al. 2013; Liang et al. 2009). 
  
 
Importantly, antioxidant therapy was able to attenuate 
or prevent diabetic complications (e.g., 
malformations) in the offspring (Badr et al. 2011; 
Cederberg et al. 2001; Eriksson and Simán 1996; 
Sakamaki et al. 1999; Simán and Eriksson 1997a, 
b; Sugimura et al. 2009; Wentzel and Eriksson 2005). 
So, antioxidant intake appears to be able to attenuate 
GDM complications in the offspring. 
 
Intrauterine growth restriction 
 
Intrauterine growth restriction (IUGR) is a pregnancy 
disorder where the fetus does not develop to full growth 
in the womb (Burton and Jauniaux 2011). The ideal 
diagnosis seems to be divided in a two-stage process: 
restriction of the growth by ultrasonography and use of 
transcerebellar diameter when gestational age is 
questionable (Mandruzzato et al. 2008). Despite 
being a multifactorial etiology pathology 
(Mandruzzato et al. 2008), most cases with no 
genetic or infectious cause are thought to be related 
to a compromised maternal blood circulation to the 
placenta, based on high- resistance uterine arterial 
waveforms and morphological studies of the spiral 
arteries (Burton and Jauniaux 2011), associated with 
deregulation of villous vasculogenesis and abundant 
fibrin deposition (Scifres and Nelson 
2009). IUGR is associated with increased risk of fetal 
mortality and morbidity (Garite et al. 2004) and 
predisposes children to an increased risk of 
hypertension, cardiovascular disorders, and renal 
diseases in adult- hood (Scifres and Nelson 2009). 
Several studies have been conducted in order to 
evaluate the relationship between IUGR and oxidative 
stress. In particular, one study evaluated four parameters 
of cell membrane injury (MDA, Schiff bases, lipid 
peroxides, and conjugated dienes) in plasma and blood 
samples, and a correlation between IUGR and an in- 
crease in these membrane-damage parameters was 
found, suggesting a role of ROS in this pathology 
(Karowicz-Bilińska et al. 2002). Also, oxidative stress 
biomarkers (MDA and protein oxidation) were 
evaluated in erythrocytes from both mother and fetus, 
and in both, oxidative stress markers were 
significantly in- creased in IUGR pregnancies 
(Kamath et al. 2006). In another study, oxidative stress 
biomarkers such as lipid peroxidation, protein, and 
DNA damage as well as antioxidant enzyme activity 
like glutathione peroxidase, superoxide dismutase, and 
catalase were evaluated in neonates with 
 IUGR. The IUGR group showed de- creased 
antioxidant levels, leading toward the conclusion that 
neonates with IUGR have significant deficiency in 
antioxidant defenses and significant increased lipid 
peroxidation (Hracsko et al. 2008). The same 
conclusions were found regarding different oxidative 
stress biomarkers, namely, malondialdehyde (MDA) 
and xanthine oxidase (XO) (Biri et al. 2007), leading 
to the general conclusion that increased oxidative 
stress and IUGR are correlated. 
When a mixture of antioxidants (vitamin C, 
cocarboxylase, and solcoseryl) was administered to 
pregnant women with IUGR, a decrease in various 
oxidative stress biomarkers (e.g., lipid peroxides) was 
observed (Karowicz-Bilińska et al. 2002). Still, no 
correlation between antioxidant therapy and IUGR 
prevention has been reported. 
 
Preeclampsia 
 
Preeclampsia (PE), which affects 2–14 % of all 
pregnancies and occurs primarily in nulliparous 
women in the third trimester, is a clinical syndrome of 
systemic inflammatory response, characterized by 
hypertension (blood pressure higher than 140/90 
mmHg) and either proteinuria (>300 mg/24 h) or end-
organ dysfunction (central nervous system dysfunction, 
hepatic abnormality, thrombocytopenia, renal 
abnormality, pulmonary edema) after 20 weeks of 
gestation in a previously normotensive woman 
(Agarwal et al. 2012; Burton and Jauniaux 2011; 
Roberts et al. 2013; Myatt and Cui 2004; Poston et al. 
2011). PE can have an early-onset development, when 
it is manifested before 34 weeks of gestation, or a late 
onset, if it develops after the 34th week of gestation 
(Agarwal et al. 2012). One of the basic pathological 
events is maternal vascular endothelial injury, which 
may favor the production of vasoconstrictors, resulting 
in vasospasms, very common in PE (Agarwal et al. 
2012; Fujimaki et al. 2011). 
The exact etiology and pathogenesis of PE is still 
unclear due to its non-specific symptoms. Nevertheless, 
there are many common maternal hallmarks in PE, such 
as a generalized arteriolar constriction and intravascular 
depletion, which can produce symptoms related to 
ischemia, necrosis, and hemorrhage of organs and 
result in poor perfusion of the maternal and fetal 
circulations of the placenta, shallow trophoblast 
invasion, significantly increased neutrophil-
endothelial 
  
 
adhesion and adhesion molecule expression, and 
abnormal increase in production of TNFα, a cytokine 
produced mainly by macrophages, among others 
(Myatt and Cui 2004). Also, an increase in protein 
carbonyls, lipid peroxides, nitrotyrosine residues, and 
DNA oxidation (common biomarkers of oxidative 
stress) has been associated with PE (Agarwal et al. 
2012; Burton and Jauniaux 2011). 
So, although the cause of PE remains largely un- 
known, oxidative stress and a generalized inflammatory 
state are features of this disease. The placenta appears to 
be the principal source of free-radical synthesis, but the 
maternal leukocytes and the maternal endothelium are 
also likely contributors (Raijmakers et al. 2004). 
Different hypothesis relate increased placental oxidative 
stress levels and PE. The first one is the vascular 
hypothesis, because early-onset PE is associated with 
a deficient conversion of the spiral arteries, and it 
has been proposed that failure in this conversion 
results in intermittent perfusion of the placenta and a 
low-grade ischemia-reperfusion type injury (Agarwal 
et al. 2012; Burton and Jauniaux 2011). Hypoxia-
reoxygenation in vitro is a potent inducer of oxidative 
stress in term placental explants, much more than 
hypoxia alone, and it has been shown that exposure of 
explants to changes in oxygenation causes generation 
of ROS within the trophoblast and endothelial cells as 
well as the formation of nitrotyrosine residues, in a 
pattern matching closely to that seen in PE placentas 
(Burton and Jauniaux 2011). Another hypothesis relates 
to NAD(P)H oxidase, which is responsible for 
generating and sensing oxidative stress levels. The 
oxidase activity was detected and c o n f i n ed t o  t h e  
m  i c r o v i l l u s  m e m br a n e  o f syncytiotrophoblast 
and might be abnormally regulated in PE pregnancies 
(Myatt and Cui 2004). However, more studies need to 
be conducted. Another hypothesis, that complements 
the first one mentioned above, suggests that ROS are 
related to PE because there is a developmental 
failure in oxygen handling by the trophoblasts, since 
maximal placental trophoblast invasion occurs at the 
end of the first trimester, when oxygen pressure 
increases abruptly (Myatt and Cui 2004). Hypoxia-
reoxygenation was found to cause apoptosis of 
syncytiotrophoblasts, which can be related with a 
shallow trophoblast invasion and consequently to in- 
creased ROS levels observed in PE. Oxidative stress 
can cause increased nitration of p38MAPK, inducing 
its catalytic activity and, in this way, cause a poor 
implantation and the growth restriction observed in PE 
 (Agarwal et al. 2012). 
Several distinct oxidative stress-related biomolecules 
have been found to be altered in PE placenta, including 
increased levels of oxidative stress biomarkers such as 
MDA and 4-hydroxynonenal (4-HNE), increased 
formation of nitrotyrosine, of xanthine oxidase activity, 
and of autoantibodies against the angiotensin AT1 
receptor, which stimulate NAD(P)H oxidase activity, 
leading to an increase in ROS production and in the 
synthesis of many placental factors, including 
microparticulate apoptotic debris, proinflammatory 
cytokines, and angiogenic factors (Agarwal et al. 
2012; Burton and Jauniaux 2011; Takagi et al. 
2004). For example, in cultured trophoblasts and 
smooth muscle cells, the AT1 receptor of PE women 
seems to promote NAD(P)H oxidase overexpression 
(Agarwal et al. 2012). However, none of these 
mentioned factors are systematically present in all cases 
of PE, which means that the real cause of this disorder 
might yet to be discovered or that it does not depend 
on only one parameter. 
Early-onset PE is almost invariably associated with 
IUGR (Burton and Jauniaux 2011). Despite having 
distinctive clinical manifestations, there is 
accumulating evidence that the two pathologies 
have a common cause: an abnormal placental 
implantation (Mert et al. 2012). Several studies have 
been conducted in order to understand if the two 
pathologies are related (Fujimaki et al. 2011; Mert et al. 
2012; Takagi et al. 2004; Wiktor et al. 2004). One 
study, using immunohistochemistry and Western 
blotting in tissue samples from normal and PE 
placentas, suggested that the oxidative damage was 
higher in placenta displaying PE together with IUGR 
when compared with placenta displaying PE alone 
(Takagi et al. 2004). Another study measured 8- 
hydroxydeoxyguanosine (8-OHdG), which is another 
well-established marker for DNA oxidative damage, to 
evaluate the oxidative damage in placental samples of 
normal, PE, and PE plus IUGR pregnant women. The 
PE plus IUGR group presented the highest 8-OHdG 
levels, with a significant difference from control. The 
PE group, however, showed no statistically significant 
difference from control (Wiktor et al. 2004). Other 
studies on the same subject showed similar 
conclusions, with oxidative stress levels being higher 
in the groups that exhibit both pathologies (Fujimaki et 
al. 2011; Mert et al. 2012). These findings suggest a 
correlation be- tween the severity of the deficiency in 
the interaction 
  
 
between cytotrophoblasts and the maternal spiral 
arteries, both representative of IUGR and PE, and the 
levels of oxidative stress (Wiktor et al. 2004). 
A Cochrane review (including 10 trials and 6,533 
women) assessed the effect of an antioxidant regimen in 
PE; in the majority of trials, the antioxidant regimen 
assessed was a combination of vitamins C and E. Of 
note, there was no significant difference between anti- 
oxidant and control groups for PE or any other primary 
outcome: severe PE, preterm birth before 37 weeks, 
small-for-gestational-age infants, or any perinatal death. 
So, evidence from this review does not support routine 
antioxidant supplementation during pregnancy to re- 
duce the risk of PE and other complications in 
pregnancy (Poston et al. 2011; Ruder et al. 2008). 
 
Spontaneous miscarriage and recurrent pregnancy loss 
 
Spontaneous abortion can be characterized by an 
unintentional pregnancy termination, before the fetus is 
considered viable or, in alternative, when the fetus’ 
weight is less than 500 g. It has an incidence of 8–20 
% of all pregnancies and is mainly a result of 
chromosomal abnormality, which accounts for 50 % 
of all miscarriages. The remaining 50 % are related 
to congenital and uterine abnormalities, infections, 
maternal diseases, and idiopathic causes (Agarwal et al. 
2012). 
By using an O2  probe in women with pregnancy 
termination before the end of the first trimester, a steep 
rise in placental O2 pressure between gestation weeks 8 
and 12, coincident with the establishment of maternal 
blood perfusion of the early placenta, was found. In the 
same study, an increase in oxidative stress biomarkers, 
such as MDA and lipid peroxides, was observed in 
placental tissue from early pregnancy losses compared 
with controls, despite upregulation of antioxidants such 
as catalase, glutathione peroxidase, and Cu/Zn and Mn 
superoxide dismutase. The authors suggested that in- 
creased ROS may result from a premature and abrupt 
establishment of maternal placental perfusion (Poston 
et al. 2011). By contrast, other studies also suggested 
that the oxidative damage to the trophoblast induced by 
premature and widespread onset of the maternal 
placental circulation is a key factor in early pregnancy 
loss, but the premature oxidative stress increase was 
concluded to result from the lack of antioxidant levels 
to neutralize the increased levels of ROS (Burton and 
Jauniaux 2011; Jauniaux et al. 2003; Myatt and Cui 
2004). 
Despite the differences observed in the mentioned 
studies, there seems to be a correlation between an 
unbalance of ROS and antioxidant levels and 
miscarriage. Therefore, an abnormal placentation 
resulting in damage of syncytiotrophoblasts may 
explain the in- creased sensitivity of the latter to 
oxidative stress during the first trimester, which may 
contribute to idiopathic recurrent pregnancy loss 
(Agarwal et al. 2012). 
Nevertheless, antioxidants intake and miscarriage 
prevention does not seem to have a correlation. 
Indeed, although obstetricians have been using vitamin 
E for years in the hope of preventing abortion (SHUTE 
1960), there is no evidence that taking antioxidant vita- 
min supplements, alone or in combination with other 
agents, prior to pregnancy or in early pregnancy, pre- 
vents miscarriage (Rumbold et al. 2005). So, further 
studies are needed. 
 
ROS and fertility-related diseases 
Endometriosis 
 
Endometriosis is a benign, estrogen-dependent, chronic, 
complex, and multifactorial gynecological disorder 
characterized by the presence of endometrial tissue out- 
side the uterus (Augoulea et al. 2009; Giudice and Kao 
2004). This pathology, which may interfere with the 
ovulation process and cause tubal occlusion (Ruder 
et al. 2008), affects women in reproductive age and is 
associated with pelvic pain and infertility (Giudice and 
Kao 2004; Gupta et al. 2006). 
Although little is known regarding this pathophysi- 
ology, ROS seem to be associated with increased growth 
and adhesion of endometrial cells to the peritoneal 
cavity, leading to endometriosis (Jackson et al. 2005). 
In several independent studies regarding this 
pathology and oxidative stress biomarkers, peritoneal 
fluid from women suffering from endometriosis was 
found to have increased levels of MDA, 8-OHdG, 8-
oxoguanine DNA glycosylase, protein carbonyls, 
interleukin-6, TNFα, interleukin-1β, interleukin-8, 
VEGF, and 8-iso- prostangladin F2-alpha (8-iso-
PGF2α) (Andrade et al.2010; Carvalho et al. 2013; 
Matsuzaki and Schubert2010; Mier-Cabrera et al. 
2011; Montuschi et al. 2004; Morrow et al. 1992; 
Rong et al. 2002; Sharma et al.2010). Furthermore, 8-
iso-PGF2α levels were concluded to be useful in 
predicting oxidative status in diseases such as 
endometriosis (Montuschi et al. 2004; Morrow et al. 
1992; Sharma et al. 2010). Moreover, a heat shock 
  
 
protein 70 (HSP70) family member (HSP70b′), known 
to be present under increased oxidative conditions, has 
been found in high concentrations in the blood of 
patients with this pathology (Lambrinoudaki et al. 
2009). Also, lower levels of antioxidants such as 
vitamins A, C, E, zinc, and copper were found in 
women with endometriosis (Mier-Cabrera et al. 2009). 
Finally, vitamin E levels were significantly decreased 
in patients with endometriosis before the beginning of 
ovulation induction, perhaps due to the fact that 
antioxidants are consumed during oxidation reactions. 
Moreover, after ovulation induction with exogenous 
gonadotropins, patients with endometriosis presented 
increased lipid peroxidation and maintained lower 
vitamin E levels, a fact that hypothetically could 
compromise oocyte quality in endometriotic 
patients. However, on the day of oocyte retrieval, both 
serum lipid peroxidation potential and vitamin E 
levels were found similar in both groups (Campos 
Petean et al. 2008). 
The accumulating data thus correlate oxidative stress 
in the peritoneal cavity and the pathogenesis of 
endometriosis (Polak and Kotarski 2010) and conclude 
that oxidative stress as a biomarker of cell injury seems 
to be a reliable quantitative test of endometriosis 
severity (Carvalho et al. 2013). 
Some studies evaluated the effect of antioxidant 
therapy for endometriosis treatment. A high 
antioxidant diet, containing vitamins A, C, and E, 
originated an increase in antioxidant enzyme activity 
as well as a decrease in oxidative stress markers after 
2 months of intervention (Mier-Cabrera et al. 2009). 
Moreover, ad- ministration of antioxidants (vitamin 
C and E) was concluded to reduce chronic pelvic pain 
and inflammatory markers in the peritoneal fluid in 
women with endometriosis (Santanam et al. 2013). All 
these findings suggest that a diet rich in antioxidants 
may help diminish endometriosis symptoms. 
 
Polycystic ovary syndrome (PCOS) 
PCOS is characterized by a number of conditions such 
as chronic anovulation, enlarged cystic ovaries, 
hyperandrogenism, infertility, and often insulin 
resistance (Agarwal et al. 2012; Ruder et al. 2008), 
despite its definition and etiology still being 
controversial (Radomski et al. 2007). Women with 
PCOS present difficulties in becoming pregnant and 
often experience spontaneous abortion, along with 
menstrual and skin disorders (Agarwal et al. 2012; 
Ruder et al. 2008), as 
well as increased risk of gestational diabetes mellitus, 
hypertension, and preeclampsia during pregnancy 
(Boomsma et al. 2006; Roos et al. 2011). 
PCOS has been associated with increased ROS 
levels, mainly due to a decrease of the antioxidant 
capacity. One study suggested that PCOS 
independently influences oxidative stress, by 
measurement of total oxidant status and total 
antioxidant capacity (Blair et al. 2013). Also, PCOS 
in neonates was found to be associated with their 
mothers’ oxidative status (Boutzios et al. 2013). 
Moreover, a correlation between insulin resistance, 
oxidative stress biomarker levels such as 
malondialdehyde, and PCOS was observed in  non-
obese women (Kurdoglu  et  al. 
2012; Macut et al. 2011) and between mitochondrial 
dysfunction, by decrease in O2  consumption and in 
GSH levels, and PCOS were found in polymorpho- 
nuclear cells (Victor et al. 2011). Finally, in some 
studies, the correlation between PCOS and oxidative 
stress seems to be more evident in obese women 
(Liu and Zhang 2012). 
I n ter e s t in gly  e nou gh ,  t he  a n t io x ida nt  N- 
acetylcysteine was found to be a safe and well- 
tolerated adjuvant to clomiphene citrate for 
improvement of ovulation and pregnancy rates in PCOS 
patients (Badawy et al. 2007; Nasr 2010; Rizk et al. 
2005; Salehpour et al. 2012). Moreover, controlled-
release alpha lipoic acid has positive effects on PCOS 
phenotype, although its effects may be exerted 
through a mechanism not involving changes in 
oxidative stress (Masharani et al. 2010). 
 
Idiopathic infertility 
 
Idiopathic infertility is usually diagnosed by 
exclusion and can be described as the inability to 
conceive during a 1-year period without use of any 
kind of  protection during intercourse; it affects 
around 15  %  of  couples in  USA  (Agarwal et  al.  
2012; Ruder et al. 2008). 
Regarding oxidative stress and idiopathic infertility, 
increased levels of ROS, and in particular of ROS 
biomarkers such as MDA, were found in this condition 
(Polak et al. 1999, 2001b), but this increase seems to 
result from decreased levels of antioxidants (GSH, α- 
tocopherol, selenium) (Agarwal et al. 2012; Wang et al. 
1997). Since the sperm is highly sensitive to oxidative 
stress, these results led to the hypothesis that peritoneal 
fluids having higher concentrations of ROS and lower 
  
 
antioxidant capacity by diffusing into the fallopian tubes 
could damage the sperm and thus block possible 
fecundation (Polak et al. 2001a). 
Moreover, oocyte quality is also affected by oxidative 
stress. During the first meiotic phase in the oocyte, as 
well in the folliculogenesis, a low level of ROS is 
required. So, it is expected that under excessive ROS 
levels, an impairment of oocyte maturation may occur in 
meiosis II, which, together with an inadequate 
intracellular antioxidant capacity, will limit a successful 
ovulation and fertilization (Poston et al. 2011). Despite 
this, the results in these studies were obtained with a 
limited number of women and, therefore, require 
further investigation. 
Fertility decline 
 
Each month, the process of oocyte growth and 
development involves meiosis I, which is targeted by 
an in- crease in ROS and inhibited by antioxidants, and 
meiosis II, which is promoted by antioxidants, 
suggesting a complex relationship between ROS and 
oxidative stress/ antioxidants in the ovary. Also, the 
increase in steroid production in the growing follicle 
causes an increase in cytochrome P450 activity, 
resulting in increased ROS formation, which is an 
important inducer of ovulation (Agarwal et al. 2012). 
Aging  of  the  oocytes  (a  decrease  in  oocyte 
quality  with  aging)  affects  many  biochemical 
 
 
 
Table 1  Summary of major changes in oxidative stress levels, antioxidant activity, and oxidative stress biomarkers in pregnancy and fertility 
diseases 
 
Pathology Changes in oxidative stress levels and oxidative stress 
biomarkers 
References 
 
GDM • Increased carbonylated proteins and 8-IP levels Al-Shebly and Mansour 2012; Coughlan et al. 2004b; 
• Increased activity and gene expression of antioxidant 
enzymes 
IUGR • Increased levels of MDA, Schiff bases, lipid 
peroxides, conjugated dienes, and protein oxidation 
• Significant deficiency in antioxidant defenses 
Lappas et al. 2010 
 
Biri et al. 2007; Burton and Jauniaux 2011; Hracsko et al. 
2008; Kamath et al. 2006; Karowicz-Bilińska et al. 
2002; Scifres and Nelson 2009 
PE • Increased levels of MDA, 8-OHdG, and 4-HNE Agarwal et al. 2012; Burton and Jauniaux 2011; Mert 
• Increased nitration of p38MAPK 
• Increased formation of nitrotyrosine and of 
autoantibodies against angiotensin AT1 receptor 
• NAD(P)H oxidase overexpression 
• Increased XO activity 
et al. 2012; Fujimaki et al. 2011; Mert et al. 2012; 
Takagi et al. 2004; Wiktor et al. 2004 
Spontaneous • Increased levels of MDA and lipid peroxides Agarwal et al. 2012; Burton and Jauniaux 2011; Jauniaux 
miscarriage and 
recurrent pregnancy 
loss 
• Significant deficiency in antioxidant defenses et al. 2003; Myatt and Cui 2004; Poston et al. 2011 
Endometriosis • Increased levels of MDA, 8-OHdG, protein carbonyls, 
IL6, TNFα, IL1β, IL8, VEGF, 8-iso-PGF2α, 
HSP70, and lipid peroxidation 
• Low antioxidants levels 
Andrade et al. 2010; Campos Petean et al. 2008; Carvalho 
et al. 2013; Matsuzaki and Schubert 2010; Mier- 
Cabrera et al. 2011; Montuschi et al. 2004; Morrow 
et al. 1992; Rong et al. 2002; Sharma et al. 2010 
PCOS                           • Increased MDA levels                                                  Blair et al. 2013; Kurdoglu et al. 2012; Macut et al. 2011 
• Decrease in antioxidant capacity 
Idiopathic infertility      • Increased MDA levels                                                  Agarwal et al. 2012; Wang et al. 1997 
• Decreased levels of antioxidants (GSH, α-tocopherol, 
selenium) 
Fertility decline            • Increase in damaged DNA, 8-OHdG                            Agarwal et al. 2012; Tarín et al. 2000; Salmon et al. 2010 
• Increased ROS-mediated damage 
 
GDM gestational diabetes, 8-IP 8-isoprostane, IUGR intrauterine growth restriction, MDA malondialdehyde, 8-OHdG 8- 
hydroxydeoxyguanosine, 4-HNE 4-hydroxynonenal, XO xanthine oxidase, IL6 interleukin-6, TNFα tumor necrosis factor alpha, IL1β 
interleukin-1β, IL8 interleukin-8, VEGF vascular endothelial growth factor, 8-iso-PGF2α 8-iso-prostangladin F2-alpha, HSP70 heat shock 
protein 70, PCOS polycystic ovary syndrome 
  
 
pathways  important  for  the  implantation  process 
and  development  of  the  embryo  (Tarín  et  al. 
2000). Recent studies have shown that low- 
quality oocytes contain increased amounts of dam- 
aged  DNA  and  chromosomal aneuploidy, 
secondary  to  age-related  dysfunctions  (Agarwal  
et  al. 2012). Most degenerative changes undergone 
by oocytes during aging may be explained by free- 
radical-mediated damage, with the mitochondrial 
electron  transport  chain  being  a  major  source  of 
ROS (Tarín et al. 2000). In one study, 8-OHdG (8- 
hydroxydeoxyguanosine) levels were found to be 
higher in aging oocytes. 8-OHdG, an oxidized 
derivative of deoxyguanosine, is the most common 
base modification  in  mutagenic  damage  and  is 
used as a biomarker of OS (Salmon et al. 2010). 
 
 
 
 
Conclusions 
 
Whether there are extensive facts or only recent 
studies in need of further investigation, the 
relationship between oxidative stress and pregnancy 
pathologies seem to be clear (Table 1). ROS can 
negatively affect all different stages of pregnancy 
and thus contribute to the development of 
pathologies such as gestational diabetes mellitus, 
IUGR, PE, miscarriage, and spontaneous abortion, 
as well as fertility-related diseases, although the 
mechanisms by which ROS play such a 
significant role in the course of pregnancy remain 
not very well defined.  Still,  it  is  clear  that  
placental  oxidative stress is a multifactorial 
process that implicates several and distinctive 
outcomes, with different degrees of severity, 
depending on the mothers’ previous  health  and  
genetic  predisposal,  as  well as on environment 
conditions. 
There is emerging enthusiasm in the use of 
antioxidants, and natural or synthetic molecules that 
mimic antioxidant enzymes are the new tools being 
developed (Agarwal et al. 2005). However, at 
present, there is little convincing evidence that 
antioxidant supplements can improve fertility or 
prevent miscarriage or PE. Nevertheless, the range 
of strategies attempted so far has not been 
extensive, and there is good evidence that well-
conducted, adequately powered trials involving other 
approaches would be of value (Poston et al. 2011). 
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